RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe

Clinical trial NCT00688623 · COMPLETED

Trial details

NCT number: NCT00688623
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced and Metastatic Silent Neuro-Endocrine Tumors Carcinoma Neuroendocrine Non Functioning Neuroendocrine Tumors (NETs)Non Syndromic Neuroendocrine Tumors Carcinoids Non Functioning

Start date: 2009-06-24
Primary completion: 2016-11-07
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.